Vytorin Class Actions Pile Up Against Merck, Schering

By Amanda Ernst

Law360, New York (February 11, 2008, 12:00 AM ET) -- Proposed class action suits are piling up against Merck & Co. and Schering-Plough Corp., claiming the drugmakers broke state consumer protection laws through the sale and marketing of cholesterol-lowering drugs Vytorin and Zetia.

The most recent complaint to launch consumer fraud claims against Merck and Schering-Plough was filed Thursday in the U.S. District Court for the District of New Jersey, a popular venue for many Vytorin suits.

Additionally, the latest suit, National Joint Power Alliance v. Merck & Co. et al., lists almost 50 similar suits...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles